| ACT Seeks hESC Clinical Trial November 20, 2009 at 7:07 pm |
| Advanced Cell Technology has become the second U.S. company to seek permission to begin clinical trials for a therapy based on human embryonic stem cells.The Santa Monica, Ca., firm said yesterday that it has applied to the FDA to start trials aimed at reversing vision loss with retinal cells created from the stem cells.The firm, which has labs in Massachusetts, is only the second business to |
| Scripps' Loring Teams with International Stem Cell Corp. November 19, 2009 at 9:51 pm |
| The Scripps Research Institute and scientist Jeanne Loring are collaborating with International Stem Cell Corp. of Oceanside, Ca., to study parthenogenic stem cells and their potential therapeutic use, it was announced today.In a news release from the company, Loring, director of the Center for Regenerative Medicine at Scripps, said, ""Parthenogenetic cell lines are uniquely valuable for our | | |
No comments:
Post a Comment